Biocompatibility FAQ
Published: June 2, 2021
View
May 26, 2021: Marking a Regulatory Milestone for EU Medical Device Manufacturers
Published: May 25, 2021
View
Packaging Pitfalls Medical Device Manufacturers Cannot Ignore
Published: May 13, 2021
View
Safe & Compliant: Mitigating Risks After Device Modifications
Published: May 4, 2021
View
FDA Qualifies New Cybersecurity Medical Device Development Tool
Published: April 28, 2021
View
MDCG Publishes New Guidance on Use of Standards Under MDR/IVDR
Published: April 21, 2021
View
Why Biocompatibility Cares about Preclinical: NAMSA and APS Discuss
Published: March 24, 2021
View
When to Go with In Vitro: Your Irritation Questions Answered
Published: February 23, 2021
View
Effective March 15: CMS Rule Regarding Medicare Coverage of Innovative Technology (MCIT) and Definition of ‘Reasonable and Necessary’
Published: February 8, 2021
View
3 Regulatory Red Flags with Medical Device Changes
Published: January 28, 2021
View
Is your Biocompatibility Program Knocking your Submission Off Track?
Published: January 27, 2021
View
U.S. FDA Releases Artificial Intelligence and Machine Learning Action Plan
Published: January 18, 2021
View
U.S. FDA Introduces Safer Technologies Program to Promote Safe, Early Access to Innovative Medical Devices
Published: January 12, 2021
View
Oh No, Another Failed Cyto!
Published: December 23, 2020
View
Intact Skin Contact Devices: To Test or Not to Test
Published: November 25, 2020
View
New Guidance: Classification of IVD under the IVDR
Published: November 24, 2020
View
